Thyrocare Technologies Ltd - THYROCARE TECH. Share Price

Sector: Healthcare | ISIN: INE594H01019
₹ 644.35 (0.01%) icon23 Apr, 2024, 12:00:00 AM
Open
₹ 647.45
Prev. Close
₹ 644.30
Turnover(lac)
₹ 251.98
Day's High
₹ 652.00
Day's Low
₹ 637.00
52 Wk High
₹ 722.65
52 Wk Low
₹ 433.00
Book Value
₹ 104.63
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 3,412.01
P/E
55.12
EPS
11.68
Div. Yield
2.79

Thyrocare Technologies Ltd KEY RATIOS

sector: Healthcare

  • CMP

    as on 4/23/2024 12:00:00 AM

    ₹ 644.35 0.05 0.01
  • Open
  • ₹ 647.45
  • Prev. Close
  • ₹ 644.3
  • Turnover(Lac.)
  • ₹ 252
  • Day's High
  • ₹ 652
  • Day's Low
  • ₹ 637
  • 52 Week's High
  • ₹ 722.65
  • 52 Week's Low
  • ₹ 433
  • Book Value
  • ₹ 104.63
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 3,412.01
  • P/E
  • 55.12
  • EPS
  • 11.68
  • Divi. Yield
  • 2.79

Thyrocare Technologies Ltd Corporate Actions

24 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2024

12:00 AM

23 Oct , 2023

12:00 AM

23 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Jul , 2023

12:00 AM

AGM

Announcement date: 18 Jul , 2023

View Details

26 Jul , 2023

12:00 AM

26 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

15 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Thyrocare Technologies Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Thyrocare Technologies Ltd SHAREHOLDING SNAPSHOT
23 April , 2024 | 11:58 PM

PROMOTER - TOTAL71.11%

Indian: 71.11%

Foreign: 0%

NON-PROMOTER - TOTAL 28.89%

Institutions: 17.78%

Non-Institutions: 11.10%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Thyrocare Technologies Ltd FINANCIALS

Thyrocare Technologies Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Thyrocare Technologies Ltd

  • GOPAL SHIVRAM HEGDE
  • Independent Director
  • Neetin Shivajirao Desai
  • Independent Director
  • VISHWAS MADHAV KULKARNI
  • Independent Director
  • RAMJEE DORAI
  • Company Sec. & Compli. Officer
  • Indumati Gopinathan
  • Independent Director
  • Dhaval Shah
  • Non-Exec & Non-Independent Dir
  • Dharmil Sheth
  • Non-Exec & Non-Independent Dir
  • Rahul Guha
  • Chairman & MD & CEO
  • Hardik Dedhia
  • Non-Exec & Non-Independent Dir
  • Prapti Ishwar Gilada
  • Independent Director
  • Harshil Jiten Vora
  • Independent Director

Summary

Thyrocare Technologies Limited was incorporated in the year January 28, 2000. The Company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. As of 31 March 2022, the Company offered 636 distinct tests and 90 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases. Their 34 profiles are administered under its reputed Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs). The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of Thyrocare Technologies, is engaged in PET-CT Scan imaging diagnostic business. NHL currently has 10 active operating PET-CT scanners in 8 imaging centers: two in Navi Mumbai, two in New Delhi, one each in Hyderabad, Central Mumbai, Western Mumbai, Baroda, Nashik and Bangalore. NHL also... Read More


Reports by Thyrocare Technologies Ltd


Reports by Thyrocare Technologies Ltd

Company FAQ

No Record Found